Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.

Pediatrics

Volumn 104, Issue 2, 1999, Pages

  Biederman, J ^a   Wilens, T ^a   Mick, E ^a   Spencer, T ^a   Faraone, S V ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT;

ADDICTION; ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CASE CONTROL STUDY; CHILD; COMPARATIVE STUDY; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MALE; REGRESSION ANALYSIS; RISK FACTOR;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; REGRESSION ANALYSIS; RISK FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 0033172862     PISSN: None     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.104.2.e20     Document Type: Article

References (0)